Literature DB >> 28573507

High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation.

Eliza W Beal1, Sylvester M Black2, Khalid Mumtaz3, Don Hayes4, Ashraf El-Hinnawi2, Kenneth Washburn2, Dmitry Tumin5.   

Abstract

BACKGROUND: High-risk donor allografts increase access to liver transplant, but potentially reduce patient and graft survival. AIMS: It is unclear whether the risk associated with using marginal donor livers is mitigated by increasing center experience.
METHODS: The United Network for Organ Sharing registry was queried for adult first-time liver transplant recipients between 2/2002 and 12/2015. High donor risk was defined as donor risk index >1.9, and 1-year patient and graft survival were compared according to donor risk index in small and large centers. Multivariable Cox regression estimated the hazard ratio (HR) associated with using high-risk donor organs, according to a continuous measure of annual center volume.
RESULTS: The analysis included 51,770 patients. In 67 small and 67 large centers, high donor risk index predicted increased mortality (p = 0.001). In multivariable analysis, high-donor risk index allografts predicted greater mortality hazard at centers performing 20 liver transplants per year (HR 1.35; 95% CI 1.22, 1.49; p < 0.001) and, similarly, at centers performing 70 per year (HR 1.35; 95% CI 1.26, 1.43; p < 0.001). The interaction between high donor risk index and center volume was not statistically significant (p = 0.747), confirming that the risk associated with using marginal donor livers was comparable between smaller and larger centers. Results were consistent when examining graft loss.
CONCLUSION: At both small and large centers, high-risk donor allografts were associated with reduced patient and graft survival after liver transplant. Specific strategies to mitigate the risk of liver transplant involving high-risk donors are needed, in addition to accumulation of center expertise.

Entities:  

Keywords:  Center volume; Donor risk index; High-volume centers; Liver transplant; Marginal graft

Mesh:

Year:  2017        PMID: 28573507     DOI: 10.1007/s10620-017-4639-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality.

Authors:  D Hayes; M G Hartwig; J D Tobias; D Tumin
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

2.  Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.

Authors:  Joris J Blok; Andries E Braat; Rene Adam; Andrew K Burroughs; Hein Putter; Nigel G Kooreman; Axel O Rahmel; Robert J Porte; Xavier Rogiers; Jan Ringers
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

3.  Impact of center volume on outcomes of increased-risk liver transplants.

Authors:  Deepak K Ozhathil; You Fu Li; Jillian K Smith; Jennifer F Tseng; Reza F Saidi; Adel Bozorgzadeh; Shimul A Shah
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

4.  Effect of centre volume and high donor risk index on liver allograft survival.

Authors:  Deepak K Ozhathil; Youfu Li; Jillian K Smith; Jennifer F Tseng; Reza F Saidi; Adel Bozorgzadeh; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

5.  Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.

Authors:  David Collett; Peter J Friend; Christopher J E Watson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience.

Authors:  L Adcock; C Macleod; D Dubay; P D Greig; M S Cattral; I McGilvray; L Lilly; N Girgrah; E L Renner; M Selzner; N Selzner; A Kashfi; R Smith; S Holtzman; S Abbey; D R Grant; G A Levy; G Therapondos
Journal:  Am J Transplant       Date:  2010-02       Impact factor: 8.086

7.  Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Authors:  Arun Jesudian; Sameer Desale; Jonathan Julia; Elizabeth Landry; Christopher Maxwell; Bhaskar Kallakury; Jacqueline Laurin; Kirti Shetty
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

8.  Center Volume Is Associated With Outcome After Pancreas Transplantation Within the Eurotransplant Region.

Authors:  Wouter Kopp; Marieke van Meel; Hein Putter; Undine Samuel; Helmut Arbogast; Wolfgang Schareck; Jan Ringers; Andries Braat
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

Review 9.  Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.

Authors:  Balázs Nemes; György Gámán; Wojciech G Polak; Fanni Gelley; Takanobu Hara; Shinichiro Ono; Zhassulan Baimakhanov; Laszlo Piros; Susumu Eguchi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-03-02       Impact factor: 3.869

10.  Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients.

Authors:  Elisa Maria de Camargo Aranzana; Adriana Zuolo Coppini; Maurício Alves Ribeiro; Paulo Celso Bosco Massarollo; Luiz Arnaldo Szutan; Fabio Gonçalves Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2015-06-01       Impact factor: 2.365

View more
  4 in total

1.  Change in Health Insurance Coverage After Liver Transplantation Can Be Associated with Worse Outcomes.

Authors:  Clifford Akateh; Dmitry Tumin; Eliza W Beal; Khalid Mumtaz; Joseph D Tobias; Don Hayes; Sylvester M Black
Journal:  Dig Dis Sci       Date:  2018-03-24       Impact factor: 3.199

2.  County Rankings Have Limited Utility When Predicting Liver Transplant Outcomes.

Authors:  Clifford Akateh; Rebecca Miller; Eliza W Beal; Dmitry Tumin; Joseph D Tobias; Don Hayes; Sylvester M Black
Journal:  Dig Dis Sci       Date:  2019-07-22       Impact factor: 3.199

3.  Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant.

Authors:  Savio G Barreto; Mark E Brooke-Smith; Eu Ling Neo; Paul Dolan; Richard Leibbrandt; Tim Emery; Robert Carroll; Alan Wigg; John W Chen
Journal:  Langenbecks Arch Surg       Date:  2019-11-20       Impact factor: 3.445

4.  Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial.

Authors:  Matteo Ravaioli; Vanessa De Pace; Andrea Angeletti; Giorgia Comai; Francesco Vasuri; Maurizio Baldassarre; Lorenzo Maroni; Federica Odaldi; Guido Fallani; Paolo Caraceni; Giuliana Germinario; Chiara Donadei; Deborah Malvi; Massimo Del Gaudio; Valentina Rosa Bertuzzo; Antonio Siniscalchi; Vito Marco Ranieri; Antonietta D'Errico; Gianandrea Pasquinelli; Maria Cristina Morelli; Antonio Daniele Pinna; Matteo Cescon; Gaetano La Manna
Journal:  Sci Rep       Date:  2020-04-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.